These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18216391)

  • 21. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
    Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
    Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Pathogenic TSH β-subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR.
    Kalveram L; Kleinau G; Szymańska K; Scheerer P; Rivero-Müller A; Grüters-Kieslich A; Biebermann H
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional characterization of five constitutively activating thyrotrophin receptor mutations.
    Wonerow P; Chey S; Führer D; Holzapfel HP; Paschke R
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):461-8. PubMed ID: 11012571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Gq Biased Small Molecule Active at the TSH Receptor.
    Latif R; Morshed SA; Ma R; Tokat B; Mezei M; Davies TF
    Front Endocrinol (Lausanne); 2020; 11():372. PubMed ID: 32676053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid-specific expression and cyclic adenosine 3',5'-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1.
    Shimura H; Okajima F; Ikuyama S; Shimura Y; Kimura S; Saji M; Kohn LD
    Mol Endocrinol; 1994 Aug; 8(8):1049-69. PubMed ID: 7997232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The "TSH Receptor Glo Assay" - A High-Throughput Detection System for Thyroid Stimulation.
    Latif R; Lau Z; Cheung P; Felsenfeld DP; Davies TF
    Front Endocrinol (Lausanne); 2016; 7():3. PubMed ID: 26858688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
    Hidaka A; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1993 Oct; 196(1):187-95. PubMed ID: 8216292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The functional expression of recombinant human thyrotropin receptors in nonthyroidal eukaryotic cells provides evidence that homologous desensitization to thyrotropin stimulation requires a cell-specific factor.
    Chazenbalk GD; Nagayama Y; Kaufman KD; Rapoport B
    Endocrinology; 1990 Sep; 127(3):1240-4. PubMed ID: 2167212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective thyrotropin receptor G-protein cyclic adenosine monophosphate signaling mechanism in the FTC human follicular thyroid cancer cell line.
    Demeure MJ; Doffek KM; Wilson SD
    Surgery; 1997 Dec; 122(6):1195-201; discussion 1201-2. PubMed ID: 9426438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal expression of two 'thyroid-specific' genes: thyrotropin receptor and thyroglobulin.
    Sellitti DF; Akamizu T; Doi SQ; Kim GH; Kariyil JT; Kopchik JJ; Koshiyama H
    Exp Nephrol; 2000; 8(4-5):235-43. PubMed ID: 10940722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP.
    Derwahl M; Kuemmel M; Goretzki P; Schatz H; Broecker M
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1131-8. PubMed ID: 8385451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proper targeting and activity of a nonfunctioning thyroid-stimulating hormone receptor (TSHr) combining an inactivating and activating TSHr mutation in one receptor.
    Agretti P; De Marco G; Collecchi P; Chiovato L; Vitti P; Pinchera A; Tonacchera M
    Eur J Biochem; 2003 Sep; 270(18):3839-47. PubMed ID: 12950268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
    Castro I; Lima L; Seoane R; Lado-Abeal J
    Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutively active thyrotropin and thyrotropin-releasing hormone receptors and their inverse agonists.
    Neumann S; Raaka BM; Gershengorn MC
    Methods Enzymol; 2010; 485():147-60. PubMed ID: 21050916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on homologous desensitization of the thyrotropin receptor in 293 human embryonal kidney cells.
    Nagayama Y; Chazenbalk GD; Takeshita A; Kimura H; Ashizawa K; Yokoyama N; Rapoport B; Nagataki S
    Endocrinology; 1994 Sep; 135(3):1060-5. PubMed ID: 8070347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upon thyrotropin binding the thyrotropin receptor is internalized and localized to endosome.
    Singh SP; McDonald D; Hope TJ; Prabhakar BS
    Endocrinology; 2004 Feb; 145(2):1003-10. PubMed ID: 14576174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSH Receptor Signaling Abrogation by a Novel Small Molecule.
    Latif R; Realubit RB; Karan C; Mezei M; Davies TF
    Front Endocrinol (Lausanne); 2016; 7():130. PubMed ID: 27729899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].
    Hoelting T; Duh QY; Clark OH; Herfarth C
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):281-4. PubMed ID: 14518260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human alpha-subunit analogs act as partial agonists to the thyroid-stimulating hormone receptor: differential effects of free and yoked subunits.
    Angelova K; Fremont V; Jain R; Zhang M; Puett D; Narayan P; Szkudlinski MW
    Endocrine; 2004 Jun; 24(1):25-31. PubMed ID: 15249700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A family with congenital hypothyroidism caused by a combination of loss-of-function mutations in the thyrotropin receptor and adenylate cyclase-stimulating G alpha-protein subunit genes.
    Lado-Abeal J; Castro-Piedras I; Palos-Paz F; Labarta-Aizpún JI; Albero-Gamboa R
    Thyroid; 2011 Feb; 21(2):103-9. PubMed ID: 21186955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.